DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
The American Made Pharmaceuticals Act of 2024 directs the Secretary of Health and Human Services to conduct a 7-year demonstration program in at least 8 states that gives preferential treatment to drugs and biologicals manufactured in the United States under Medicare, Medicaid, and CHIP. Preference mechanisms may include formulary placement, lower cost-sharing, waived rebates, Star Ratings, or bonus payments. Eligible drugs must be manufactured by U.S.-based companies meeting specified criteria, including maintaining domestic manufacturing locations and sourcing at least 50 percent of starter products from non-covered nations after three years.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.